Literature DB >> 15620840

Biophysical and biochemical properties of a binary lipid mixture for DNA transfection.

D Mirska1, K Schirmer, S S Funari, A Langner, B Dobner, G Brezesinski.   

Abstract

The phase and miscibility behavior of a triple-chain phosphatidylcholine (TPHPC) and a single-chain surfactant (CTAB) were investigated in aqueous dispersions and in monolayers at the air/water interface. CTAB can be incorporated in the TPHPC monolayer because of its complementary molecule shape and reduces the tilt angle of TPHPC. The type of phases and the phase sequence (L2 - LS) are the same in the pure TPHPC monolayer and in the TPHPC/CTAB (80:20 mol:mol) mixture. No indication of any ordering of adsorbed DNA was observed. In the aqueous dispersions, TPHPC exhibits an inverted hexagonal phase above the chain melting. The addition of 30 mol% CTAB leads to the appearance of a lamellar Lalpha phase. The binding of DNA to the mixture is obvious but this is accompanied by a separation of the two lipids what is supported by monolayer experiments. The system has no long-term stability. The main reason seems to be not only the stronger interaction of DNA with CTAB, but also especially the unexpected weak interaction between CTAB and TPHPC. The transfection efficiency is lower compared with lipofectamine. The main disadvantage of this system is the cytotoxicity of CTAB, which could not be lowered by incorporation of CTAB in the TPHPC bilayer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620840     DOI: 10.1016/j.colsurfb.2004.10.007

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  10 in total

1.  Controlling the cellular uptake of gold nanorods.

Authors:  Terry B Huff; Matthew N Hansen; Yan Zhao; Ji-Xin Cheng; Alexander Wei
Journal:  Langmuir       Date:  2007-02-13       Impact factor: 3.882

Review 2.  Hyperthermia using nanoparticles--Promises and pitfalls.

Authors:  Punit Kaur; Maureen L Aliru; Awalpreet S Chadha; Alexzander Asea; Sunil Krishnan
Journal:  Int J Hyperthermia       Date:  2016-01-12       Impact factor: 3.914

3.  Three-dimensional optoacoustic imaging as a new noninvasive technique to study long-term biodistribution of optical contrast agents in small animal models.

Authors:  Richard Su; Sergey A Ermilov; Anton V Liopo; Alexander A Oraevsky
Journal:  J Biomed Opt       Date:  2012-10       Impact factor: 3.170

4.  Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications.

Authors:  Dmitri Lapotko
Journal:  Nanomedicine (Lond)       Date:  2009-10       Impact factor: 5.307

5.  Bioconjugates of Glucose Oxidase and Gold Nanorods Based on Electrostatic Interaction with Enhanced Thermostability.

Authors:  Zhanfang Ma; Teng Ding
Journal:  Nanoscale Res Lett       Date:  2009-07-15       Impact factor: 4.703

6.  Detoxification of gold nanorods by treatment with polystyrenesulfonate.

Authors:  Alexei P Leonov; Jiwen Zheng; Jeffrey D Clogston; Stephan T Stern; Anil K Patri; Alexander Wei
Journal:  ACS Nano       Date:  2008-12-23       Impact factor: 15.881

7.  Plasmonic nanobubbles as tunable cellular probes for cancer theranostics.

Authors:  Dmitri Lapotko
Journal:  Cancers (Basel)       Date:  2011-02-23       Impact factor: 6.639

8.  Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo.

Authors:  Jiali Wan; Jia-Hong Wang; Ting Liu; Zhixiong Xie; Xue-Feng Yu; Wenhua Li
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

Review 9.  Coating Matters: Review on Colloidal Stability of Nanoparticles with Biocompatible Coatings in Biological Media, Living Cells and Organisms.

Authors:  Jonas Schubert; Munish Chanana
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

10.  Newly synthesized water soluble cholinium-purpurin photosensitizers and their stabilized gold nanoparticles as promising anticancer agents.

Authors:  Dorjnamjin Demberelnyamba; Mama Ariunaa; Young Key Shim
Journal:  Int J Mol Sci       Date:  2008-05-23       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.